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Summary 
Inhibition of glucose-6-phosphate dehydrogenase (G6-
PDH) by dithranpl (anthralin, CAS 480-22-8) has been 
studied in the presence of catalase, superoxide dismutase 
(SOD) and various scavengers of active oxygen species. 
Most scavengers were found to be either inhibitors of G6-
PDH by themselves or simply without effect. The com-
bined addition of catalase and SOD as well as the heat-
denatured enzymes and the oxygen radical scavengers a-
tocopherol and salicylic acid markedly reduced the inhi-
bitory effect of dithranol. The direct exposure of G6-PDH 
to active oxygen species led to different results. When lib-
erated from a water-soluble naphthalene endoperoxide, 
singlet oxygen was without effect whereas photosensiti-
zation with methylene blue resulted in a total loss of en-
zyme activity. Experiments under anaerobic conditions 
revealed that this inhibition was accomplished by the tri-
plet state of the sensitizer. Superoxide anion radical was 
highly effective at concentrations corresponding to the 
amount of that produced by a 10 nmol/l dithranol solu-
tion. In contrast, hydroxyl, alkylperoxyl and alkoxyl rad-
icals were all less efficient. H202 and alkylhydroperoxides 
did not alter the enzyme activity. The results suggest that 
Of is the potent species towards G6-PDH, if dithranol 
acts through formation of active oxygen species. 
Zusammenfassung 
Dithranol, Glucose-6-phosphat-Dehydrogenase-Hemmung 
und aktive Sauerstoffspezies 
Glucose-6-phosphat-Dehydrogenase (Gö-PDH)-Hem-
mung durch Dithranol (Anthralin, CAS 480-22-8) wurde 
in Gegenwart von Catalase, Superoxid-Dismutase (SOD) 
und verschiedenen Fängern für aktive Sauerstoffspezies 
untersucht. Die meisten Fänger waren entweder selbst 
Hemmstoffe der G6-PDH oder wirkungslos. Sowohl die 
kombinierte Zugabe von Catalase und SOD als auch die 
denaturierten Enzyme, ebenso die Sauerstoffradikalfän-
ger a-Tocopherol und Salicylsäure zeigten eine deutliche 
Reduzierung der durch Dithranol verursachten Hemmefi 
fekte. Die direkte Einwirkung von aktiven Sauerstoffspe-
zies auf G6-PDH führte zu unterschiedlichen Resultaten. 
Freisetzung von Singulett-Sauerstoff aus einem wasser-
löslichen Endoperoxid war ohne Effekt, hingegen führte 
die Photosensibilisierung mit Methylenblau zum vollstän-
digen Verlust der Enzymaktivität. Experimente unter an-
aeroben Bedingungen zeigten jedoch, daß diese Hem-
mung durch den Triplett-Zustand des Sensibilisators ver-
ursacht wurde. Superoxid-Anion-Radikal erwies sich in 
Konzentrationen, die von einer 10 jumol/l Dithranol-Lö-
sung produziert werden, als hochwirksam. Hydroxyl-, 
Alkylperoxyl- und Alkoxyl-Radikale waren hingegen we-
niger wirksam. H202 und Alkylhydroperoxide führten zu 
keiner Beeinträchtigung der Enzymaktivität. Die Resul-
tate deuten darauf hin, daß Oy die potente Spezies der 
G6-PDH-Hemmung durch Dithranol ist, wenn diese über 
die aktiven Sauerstoffspezies erfolgt. 
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1. Introduction Hl- ^ n e m ° d e of action o f the drug at the molecular level 
is still not known in detail, but it may act, at least in part, 
Di thranol (anthralin, l a ; C A S 480-22-8) has been used as on mainly four cellular targets: a) interaction with D N A 
an effective topical antipsoriatic drug for over 70 years [2—6], b) alteration o f mitochondrial functions [7—10], 
c) inhibi t ion of the 5- and 12-lipoxygenase pathways of 
arachidonic acid metabolism [11 — 13], and d) inhibitory 
action on cytosolic enzymes of the glycolytic pathway, 
such as glucose-6-phosphate dehydrogenase ( G 6 - P D H ) 
Institute of Pharmacy, University of Regensburg [14—18]. This key enzyme of the hexose monophosphate 
(Fed. Rep. of Germany) shunt is elevated in psoriatic skin [19, 20]. In view of the 
instability o f dithranol in weakly basic aqueous solution 
[18], it is unl ikely that the molecule itself is responsible 
for the biological properties. Consequently, the inh ib i -
tory effects might be related to decomposit ion products 
formed during the autoxidation o f dithranol [18]. Since 
the only two known oxidation products, the dimer bian-
throne and the anthraquinone danthron (3), are only 
moderate inhibitors o f G 6 - P D H , it has been suggested 
that other breakdown products must be the most active 
species towards G 6 - P D H [18]. 
The free radical mechanism o f di thranol oxidat ion starts 
wi th deprotonation followed by electron abstraction to 
give l,8-dihydroxy-9-anthrone-10-yl-radical (2) [21, 22]. 
Because o f its stability and inertness towards oxygen this 
radical was discounted as an important intermediate 
[23]. In the presence of oxygen, the univalent reduction 
of oxygen by di thranol anion results in the formation of 
superoxide anion ('0 2") [24, 25] (Scheme 1 (1)), dismu-
tation o f this species generates hydrogen peroxide [24], 
and by the iron-catalyzed Haber-Weiss-reaction the far 
more reactive hydroxyl radical ( O H ) is produced [26]. 
Photochemically, electronically excited molecular oxy-
gen (singlet oxygen, ! 0 2 ) is produced by the dithranol 
anion ( lb) [27, 28], which in turn is ox id ized to danthron 
(3, Scheme 1 (2)) i n a self-sensitized process most prob-
ably v i a an endoperoxide [27]. 
OH O OH 
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Scheme 1 
Although this production o f active oxygen species in vi tro 
by di thranol is well documented, it has not yet been es-
tablished whether this property is relevant to the mech-
anism o f action o f anthralin on biological targets. D i t h -
ranol interacts irreversibly wi th G 6 - P D H [18]. Irrevers-
ible inh ib i t ion may be derived from an undetermined re-
dox pathway involv ing oxygen radicals generated by 
dithranol, resulting in an inactive enzyme through de-
struction o f specific amino acids, particularly histidine 
and tryptophan [29]. Studies not related to di thranol 
showed that the membrane-bound S H enzyme glyceral-
dehyde-3-phosphate dehydrogenase was inhibi ted by ox-
idat ion o f the S H groups by active oxygen species [30]. 
The objective o f the present study was to assess the role 
o f active oxygen species in the inhibi tory action on G 6 -
P D H by dithranol . Th is inh ib i t ion is u t i l ized for a first 
screening for antipsoriatic activity to date [31, 32]. D i s -
regarding the question whether G 6 - P D H inhib i t ion is a 
significant mechanism for the mode o f action or not we 
f ind this test a useful tool in our efforts to obtain more 
insight into the nature o f the inhibi tory species. If di th-
ranol acts through active oxygen formation, addit ion of 
catalase, superoxide dismutase (SOD), and various oxy-
gen radical scavengers to the reaction system should can-
cel or d imin i sh the rate of inactivation of G 6 - P D H by 
dithranol. Another approach which would allow us to un-
derstand the influence of oxygen derivatives on this re-
action system is to test the effects of active oxygen species 
— generated independently o f dithranol — on G 6 - P D H 
activity. 
Abbreviations 
B A S — bovine serum a lbumin 
D A B C O - l ,4-diazabicyclo[2.2.2] octane 
D T P A — diethylenetriaminepentaacetic acid 
E D T A — ethylenediaminetetraacetic acid 
G 6 - P — glucose-6-phosphate d i sodium salt 
G 6 - P D H — glucose-6-phosphate dehydrogenase ( E C . 1.1.1.49) 
H S A — human serum a lbumin 
N A D P + — nicot inamide adenine dinucleotide phosphate diso-
d i u m salt 
N B T — nitro blue tetrazolium 
N D P 0 2 — endoperoxide o f 3,3 ,-(l,4-naphthylene)dipropionate 
N D G A — nordihydroguaiaretic acid 
S O D — superoxide dismutase ( E C . 1.15.1.1) 
X O — xanthine oxidase ( E C . 1.1.3.22) 
2. Materials and methods 
2.1. Chemicals 
Dithrano l (anthralin, l ,8-dihydroxy-9(10H)-anthracenone) was 
prepared by reduction o f danthron [33] and purified by column 
chromatography ( S i 0 2 / C H 2 C 1 2 ) ; N D P 0 2 was prepared accord-
ing to the method o f Xubry [34]; B S A , ß-caro tene , catalase from 
bovine l iver ( E . C 1.11.1.6; 20000 U / m g protein), chelating resin 
(sodium form), deferoxamine mesylate, 2 ,2 ' -dipyridyl , D T P A , 
G6-P , glutathione, H S A , N A D P ^ , N D G A , propyl gallate, pyro-
gallol , S O D from bovine erythrocytes (2800 U / m g protein), xan-
thine, X O (Sigma, M u n i c h , F R G ) , cumene hydroperoxide, 
E D T A , F e C l 3 • 6 H 2 0 , F e S 0 4 • H 2 0 , hydrogen peroxide (30 %), 
manni tol , methylene blue, N B T , sodium citrate, a-tocopherol (E. 
Merck , Darmstadt, F R G ) , ß-a lanine , ascorbic acid, L-cysteine, 
D A B C O , glycine, rose bengal, salicylic acid, L-serine, sodium 
benzoate, thiourea (Aldr ich , Steinheim, F R G ) . G 6 - P D H (350 U / 
mg protein; Boehringer M a n n h e i m G m b H , Mannhe im , F R G ) , 
tert-butyl hydroperoxide (Janssen, Nettedal, F R G ) . 
2.2. G6-PDH assay 
Incubation experiments were performed in a Ringer buffer com-
posed o f 140 mmol/1 N a C l , 2.7 mmol/1 K C l , 5 mmol/1 N a H C 0 3 , 
1.8 mmol/1 C a C l 2 and 1.1 mmol/1 M g C l 2 at p H 7.5. The com-
mercial enzyme suspension (350 U/mg) was diluted 1:2000 in 
the buffer and kept in an ice bath (at t ime zero the control ac-
t ivi ty was 70 U / l ) . Di th rano l stock solutions (4.4 mmol/1 in ac-
etone) were kept in the dark under N 2 . In typical runs G 6 - P D H 
activity was determined in four different incubation sets (final 
volume - 5 ml) consisting o f (a) 4.48 m l o f Ringer buffer, 0.5 
m l o f enzyme solution and 0.02 m l acetone, (b) 4.48 m l o f Ringer 
buffer, 0.5 m l o f enzyme solution and 0.02 ml o f di thranol stock 
solution, (c) 3.98 ml o f Ringer buffer, 0.5 ml o f enzyme solution, 
0.5 m l o f oxygen scavenger solution and 0.02 m l acetone, and 
(d) 3.98 m l o f Ringer buffer, 0.5 ml o f enzyme solution, 0.5 ml 
of oxygen scavenger solution and 0.02 m l o f di thranol stock so-
lut ion. Test solutions were incubated for 1 h at 37 °C in a shaking 
thermostat bath in the dark. After incubation, 0.5 ml o f the test 
solution was pipetted in a 3.0 m l cell , 2.4 m l o f Ringer buffer 
and 0.05 m l o f a 0.03 mmol/1 N A D P + solution were added, 
mixed and kept for 5 m i n at 25 °C. After addi t ion o f 0.05 ml o f 
a 0.04 mmol/1 G 6 - P solution the rate o f increase in absorbance 
at 339 nm was measured over a period o f 5 m i n on a U v i k o n 
810 spectrophotometer (Kont ron Instruments, Eching, F R G ) . 
2.3. Catalase assay 
Catalase activity was measured following the decomposit ion o f 
H 2 0 2 at 240 n m [35]. React ion mixtures contained 1.98 m l o f 
phosphate buffer, 1 m l o f 0.03 mmol/1 H 2 0 2 and 0.02 ml o f en-
zyme d i lu t ion (2 U / m g protein). Incubation experiments for the 
determination o f catalase inh ib i t ion by dithranol were per-
formed for 30 m i n at 37 °C in a shaking thermostat bath under 
light protection. Cont ro l : acetone. 
2.4. SOD assay 
S O D activity was determined by measuring the inhibi t ion of py-
rogallol autoxidation, monitored spectrophotometrically at 420 
nm [36]. Incubation experiments for the determination of S O D 
inhib i t ion by dithranol were performed for 60 m i n at 37 °C in a 
shaking thermostat bath in the dark. Contro l : acetone. 
2.5. Active oxygen species generating systems 
A l l incubation experiments for G 6 - P D H inhibi t ion by active ox-
ygen species were performed aerobically in a phosphate buffer 
composed of 50 mmol/1 K 2 H P 0 4 • 3 H 2 0 and 5 mmol/1 K H 2 P 0 4 
at p H 7.8 under shaking. Incubation mixtures contained 4.47 or 
4.48 ml of phosphate buffer, 0.5 ml o f enzyme solution and 0.02 
or 0.03 ml o f an active oxygen generating system. Incubation 
time was 30 min . 
' 0 2 was produced either by means of a dye-sensitized photo-
chemical method or with a chemical source. In the case o f pho-
tosensitized oxidations the incubation mixtures were irradiated 
with a cooled halogen lamp (Osram Halostar, 100 W) in the pres-
ence of rose bengal or methylene blue ( 1 0 5 mmol/1), respectively. 
A 1 % solution o f K 2 C r 2 0 7 in H 2 0 was used as a cutoff filter (550 
nm). Controls: A r / i n the dark. As a chemical source the decom-
posit ion o f the water-soluble N D P 0 2 [34, 37] (Scheme 2) was 
used. 
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The decomposit ion o f the endoperoxide was examined at 37 °C 
in the phosphate buffer described above. The disappearance o f 
N D P 0 2 (10 umol/1 in the incubation mixture o f 5 ml) was mon-
itored by H P L C (Kont ron 420, column: Nucleosil-100 R P 18; 
methanol/water/acetic acid (77:23:0.1); U V detection at 232 nm, 
Kon t ron U v i k o n 735 L C ) . The first order rate constant was 4.2 
± 0.2 • 1 0 4 s"1 which corresponds to a half-life o f 28 min . 
In order to produce a flux o f 0 2 " a system o f X O and xanthine 
was used [38, 39]. Generat ion o f 0 2 was ascertained spectro-
photometrically by monitor ing the reduction of N B T at 560 nm 
[40]. The amounts o f X O (0.02 U / m l ) and xanthine (30 umol/1) 
used were chosen on the basis o f an I C 5 0 o f dithranol for G 6 -
P D H of about 10 umol/1. Thus, the system was adjusted in such 
a manner that the reduction rate o f N B T corresponded to 55 % 
[24] o f that caused by a 10 umol/1 dithranol solution (45 % o f 
N B T reduction are due to direct electron transfer from dithranol 
to N B T , for details on 0 2 " production during dithranol autoxi-
dation see [24]). X O was added last to initiate the reaction. The 
phosphate buffer solution was passed through a column o f che-
lating resin to remove traces o f iron [41]. D T P A [42, 43] (0.1 
mmol/1) or deferoxamine mesylate [44] (0.1 mmol/1) was added 
to prevent O H formation. 
O H was generated from the xan th ine /XO system either by ad-
di t ion o f F e 3 + - E D T A [42, 45] (iron-catalyzed Haber-Weiss re-
action) or F e 2 + - D T P A [46] (superoxide driven Fenton reaction). 
The final concentrations in the reaction mixtures were 0.1 m m o l / 
1 for F e C l 3 • 6 H 2 0 or F e S 0 4 • H 2 0 , respectively. Controls were 
performed with the ferrous salt, H 2 0 2 , xanthine, and the chela-
tors alone. Addi t iona l ly , hydroxyl radicals were produced in a 
Fenton reaction with hydrogen peroxide and F e 2 + - D T P A [46]. 
H 2 0 2 was added last in three portions (final concentration 0.18 
mmol/1) to initiate the reaction. 
A l k o x y l radicals were generated by the catalytic decomposition 
of tert-butyl hydroperoxide [47] and cumene hydroperoxide by 
F e 2 + -d ipyr idyl [48], whereas F e 3 + as a catalyst was employed to 
predominantly generate alkylperoxyl radicals [49, 50]. Incuba-
t ion experiments contained 0.1 mmol/1 o f the alkylhydroperox-
ide, 0.1 mmol/1 ferrous d ipyr idy l or iron D T P A , respectively. 
3. Results and discussion 
3.1. Effects of catalase and SOD 
on the system G6-PDH/dithranol 
Since dithranol was reported to lower the activities of 
both the enzymes [51], we examined the activities of cat-
alase and S O D as a function o f dithranol concentration. 
The I C 5 0 o f dithranol for catalase was found to be 5 umol/ 
1 (Fig. 1). W i t h a dithranol concentration of 1.7 • 1 0 5 
mol/1 catalase activity decreased to about 70 % of ini t ial 
activity after 30 min of incubation (Fig. 2). Although this 
inhibi t ion of catalase by dithranol has to be considered, 
there still remains sufficient activity for studying the ef-
fect of catalase on G 6 - P D H inhib i t ion by dithranol under 
these conditions. 
Contrary to catalase the maximal degree of inhibi t ion of 
S O D that could be achieved was 35 % (Fig. 3), even at 
higher concentrations of dithranol. 
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Fig. 1: Inhibition of catalase as a function of dithranol concentration (ab-
scissa). Incubation mixtures contained catalase (5 ug/ml) and indicated 
concentrations of dithranol in a final volume of 1 ml phosphate buffer for 
30 min at 37 °C in a shaking water bath. Results are the average of 3 ex-
periments (SD < 5 %). 
Fig. 2: Time course of inhibition of catalase by dithranol. Incubation 
mixtures contained catalase (5 ug/ml) and 1.7 x 10 5 mol/1 dithranol in a 
final volume of 1 ml phosphate buffer for 30 min at 37 °C. Results are the 
average of 3 experiments (SD < 5 %). 
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Fig. 3: Inhibition of SOD as a function of dithranol concentration (ab-
scissa). Incubation mixtures contained SOD (10 ug/ml) and indicated con-
centrations of dithranol in a final volume of 2 ml phosphate buffer for 1 h 
at 37 °C in a shaking water bath. Results are the average of 3 experiments 
(SD < 5 %). 
Data from Table 1 reveal that neither catalase nor S O D 
show significant changes in di thranol efficacy towards 
G 6 - P D H when added to the incubation sets. O n the other 
hand, combined treatment with catalase and S O D at high 
concentrations markedly lowered inhibi tory action on 
G 6 - P D H by dithranol. The combined addit ion of the en-
zymes to the system removes both H 2 0 2 (catalase) and 
0 2 " (SOD) , and — by interaction o f these two species — 
O H as a secondary reaction product, as previously 
shown for di thranol [26]. However, the denatured en-
zymes were effective, too. Moreover, addi t ion of the pro-
teins B S A or H S A led to a total loss o f inhibi tory action. 
S imi la r although weaker effects were obtained with 
amino acids. 
These results allow two possible explanations for the de-
crease of G 6 - P D H inhib i t ion by dithranol. First ly, they 
suggest an interaction of dithranol with proteins or 
amino acids. Observations from other studies that di th-
ranol is partially bound or inactivated by serum proteins 
[17, 52—54] are in agreement with this interpretation. 
Secondly, it is known that even catalase and S O D pro-
Table 1: Effects of catalase, SOD, proteins and amino acids on G 6 - P D H 
inhibition by dithranol. 
Scavenger added % Inhibition 
None 6 8 ± 4 a > 
Catalase (2 U/ml) 66 + 2 
Catalase (300 U/ml) 52 + 4 
Superoxide dismutase (28 U/ml) 6 5 ± 6 
Superoxide dismutase (175 U/ml) 5 5 ± 2 
Catalase (300 U/ml) + superoxide dismutase (175 U/ml) 1 4 ± 1 
Heated catalase (300 U/ml) + heated superoxide 
dismutase (175 U/ml) 1 7 ± 3 
BSA (30 ug/ml) 0 
HSA (30 jig/ml) 0 
ß - A l a n i n e ( 1 . 6 x 10 4 mol/1) 
L-Cysteine (1.6 x 10"4 mol/1) 
Glutathione (1.6 x 10 4 mol/1) 
6 0 ± 3 
31 ± 4 
4 4 ± 5 
Glycine (1.6 x 10 4 mol/1) 5 0 ± 1 
L-Serine(1.6 x 10 4 mol/1) 3 8 ± 5 
Incubation mixtures contained 7 mU/ml G 6 - P D H , 1.7 x 10 5 mol/1 dith-
ranol and indicated concentrations of scavengers at 37 °C in Ringer buffer 
(30 min). % Inhibition is expressed as mean ± SD; n > 3. All scavengers 
added did not impair the enzyme activity (controls without dithranol). a ) 
n = 22. 
teins (e.g. the inactive enzymes) react with active oxygen 
derivatives [55]. The same is true for other proteins i n -
cluding heat-denatured S O D and catalase [55]. A m i n o 
acids are highly reactive wi th O H radicals [56]. Thus, 
scavenging o f active oxygen species produced by di th-
ranol may be responsible for the observed decline o f 
G D 6 - P D H inhib i t ion in the presence of catalase, S O D 
and proteins. 
Table 2: Effects of singlet oxygen quenchers and oxygen radical scavengers 
on G 6 - P D H inhibition by dithranol. 
Scavenger added % Inhibition without dithranol % Inhibition 
None 0 6 8 ± 4 a ) 
Ascorbic acid (1.6 x 10 4 mol/1) 28 ± 1 8 4 ± 4 
ß-Carotene (8 x 10 6 mol/1) 4 4 ± 6 81 ± 5 
D A B C O (1.6 x 10-3 mol/1) 0 9 3 ± 1 
Mannitol (1.6 x 10 3 mol/1) 0 7 8 ± 3 
N D G A (1.6 x 10-5 mol/1) 100 100 
Propyl gallate (1.6 x 10 6 mol/1) 100 100 
Pyrogallol (1.6 x 10 6 mol/1) 
Salicylic acid (1.6 x 10*4 mol/1) 
Sodium benzoate (1.6 x 10 3 mol/1) 
100 100 
0 5 6 ± 1 
0 7 6 ± 2 
Sodium citrate (1.6 x 10 4 mol/1) 0 7 2 ± 3 
Thiourea (1.6 x 10 3 mol/1) 0 84 + 2 
a-Tocopherol (3.2 x 10 5 mol/1) 2 9 ± 6 5 0 ± 6 
Incubation mixtures contained 7 mU/ml G 6 - P D H , 1.7 • 10 5 mol/1 dith-
ranol and indicated concentrations of scavengers at 37 °C in Ringer buffer 
(30 min). % Inhibition is expressed as mean ± SD; n > 3 . a ) n = 22. 
Our results demonstrate that most o f the oxygen radical 
scavengers were G 6 - P D H inhibitors by themselves at 
concentrations necessary for the inactivation of oxygen 
free radicals produced by dithranol. This indicates that 
experiments with the system G6-PDH/di th ranol / scav-
enger are not much of an appropriate tool in search of 
the active intermediate towards G 6 - P D H . 
3.3. Effects of active oxygen species 
on G6-PDH activity 
If the toxic effects o f dithranol on G 6 - P D H occurred by 
oxygen free radicals or singlet oxygen, a direct exposure 
o f the enzyme to these species should lead to loss o f ac-
tivity. Since dithranol inhibi ted this enzyme at an I C 5 0 
value of about 10 umol/1 (Fig. 4), the effects o f active 
oxygen species on G 6 - P D H activity were tested at con-
centrations corresponding approximately to the amount 
o f active oxygen species generated by a 10 umol/1 dith-
ranol solution. 
3.3.1. Singlet oxygen 
' 0 2 causes damage to a variety o f biological targets [59]. 
Destruction of key active-site amino acids leads to inac-
t ivat ion o f many enzymes. Indeed, studies on G 6 - P D H 
photooxidation by rose bengal resulted in a specific de-
struction of histidine residues [60]. In this study we made 
use o f two different 1 0 2 -sources. Photosensitization with 
rose bengal leading to a total loss o f activity (Table 3, 
entry 1) was consistent with a previous report [60]. H o w -
ever, pertinent experiments in the dark revealed that 
even ground-state rose bengal is an inhibi tor o f G 6 - P D H . 
Contrary, the ^ - s e n s i t i z e r methylene blue d id not in -
hibit the enzyme in the dark. Although photosensitiza-
3.2. Effects of singlet oxygen quenchers and oxygen 
radical scavengers on the system G6-PDH/dithranol 
W i t h the exception o f the singlet oxygen quenchers ß-
carotene [57] and ascorbic acid [58], scavengers o f oxy-
gen radicals, such as mannitol , sodium benzoate, sodium 
citrate, salicylic acid, and thiourea d i d not influence G 6 -
P D H activity o f controls (no dithranol) to an appreciable 
amount (Table 2). Higher concentrations of scavengers 
d i d inhibi t G 6 - P D H activity. In addi t ion, the free radical 
scavengers N D G A , propyl gallate and pyrogallol are 
stronger inactivators o f G 6 - P D H than dithranol. Pert i-
nent experiments revealed that addi t ion of only small 
amounts o f these scavengers resulted in a total loss o f 
enzyme activity. O f all tested compounds only a-tocoph-
erol, although an inhibi tor by itself, and salicylic acid d i d 
weaken the inhibi tory effect o f di thranol. 
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Fig. 4: Inhibition of G 6 - P D H as a function of dithranol concentration (ab-
scissa). Incubation mixtures contained 7 mU/ml G 6 - P D H and indicated 
concentrations of dithranol in a final volume of 5 ml phosphate buffer at 
37 °C in a shaking water bath (30 min). Results are the average of three 
experiments (SD < 5 %). 
Table 3: Effects of active oxygen species on G6-PDH. 
Entry Active oxygen species-generating system % Inhibition 
1 
2 
3 
4 
5 
6 
•o2 rose bengal (10 umol/l)/O2/100 W 
rose bengal (10 umol/l)/darka) 
methylene blue (10 umol/l)/O2/100 W 
methylene blue (10 umol/l)/Ar/100 Wa> 
methylene blue (10 (imol/l)/darka) 
N D P 0 2 (10 umol/1) 
100 
100 
100 
100 
0 
0 
7 
8 
9 
o2- xanthine (30 umol/l)/XO (0.02 U/ml/ 
D T P A (100 mmol/1) 
xanthine (30 umol/l)/XO (0.02 U/ml)/ 
EDTA(100 umol/1) 
xanthine (30 umol/l)/XO (0.02 U/ml)/ 
deferoxamine (100 umol/1) 
6 0 ± 3 
6 2 ± 5 
5 9 ± 4 
10 
11 
0 2 / O H xanthine (30 umol/l)/XO (0.02 U/ml)/ 
D T P A (100 umol/l)/Fe2+ (100 umol/1) 
xanthine (30 umol/l)/XO (0.02 U/ml)/ 
E D T A (100 umol/l)/Fe 3 + (100 umol/1) 
5 9 ± 4 
5 9 ± 4 
12 
13 
14 
' O H FeS0 4 (100 umol/ l) /H 2 0 2 (180 umol/1)/ 
D T P A (100 umol/1) 
FeSO 4(100 umol/l) a ) 
FeS0 4 (100 umol/l)/DTPA (100 umol/ 
l) a ) 
1 6 ± 1 
1 7 ± 1 
2 ± 0 
15 H 2 0 2 H 2 O 2 (100 umol/1) 0 
16 
17 
R O O H tert-butyl hydroperoxide (100 umol/1) 
cumene hydroperoxide (100 umol/1) 
0 
0 
18 
19 
RO' tert-butyl hydroperoxide (100 umol/1)/ 
dipyridyl-Fe2 + (100 umol/1) 
cumene hydroperoxide (100 umol/l)/di-
pyridyl-Fe 2 + (100 umol/1) 
1 4 ± 1 
1 2 ± 1 
20 R O O ' cumene hydroperoxide (100 umol/1)/ 
D T P A (100 umol/l)/Fe 3 + (100 umol/1) 
1 7 ± 1 
Incubation was performed for 30 min at 37 'C in phosphate buffer. Incu-
bation mixtures contained 7 mU/ml G 6 - P D H and indicated concentra-
tions of active oxygen generating systems (% inhibition is expressed as 
mean ± SD; n > 3). Controls with xanthine, X O or the chelators alone 
did not impair the enzyme activity. a ) Control. 
t ion with methylene blue completely inactivated G 6 -
P D H , experiments performed under anaerobic condi-
tions (argon) led to s imilar results demonstrating that en-
zyme inactivation was caused by the triplet state of meth-
ylene blue, i.e. i n a ^ - i n d e p e n d e n t fashion. Since pho-
tosensi t izes may also interact directly with the substrate 
resulting i n hydrogen atom or electron transfer to pro-
duce radicals [59], reactions that are not l02 mediated 
are likely. O n the other hand, preparation of l02 from 
naphthalene endoperoxides (Table 3, entry 6) [61] seems 
to be a clean source, since no side reactions have yet been 
reported. l02 generated by the thermal decomposition of 
the water-soluble N D P 0 2 was completely ineffective. 
This result clearly rules out any effectiveness of l02 to-
wards G 6 - P D H . 
3.3.2. Hydrogen and alkyl peroxides, hydroxy!, alkoxyl 
and alkylperoxyl radicals 
Beside electronically excited molecular oxygen, reactive 
species include H 2 0 2 and ' 0 2 \ Furthermore, there are 
stronger oxidants derived from these oxygen intermedi-
ates, such as ' O H radicals [42, 45, 62]. Results from our 
work do not point to deleterious effects of H 2 0 2 , O H , 
R O O H , RO* and R O O * towards G 6 - P D H (Table 3, en-
tries 12—20). The enzyme activity was only slightly i n -
hibited by O H generated by the Fenton reaction (Table 
3, entry 12). Surprisingly, Fe 2 + alone showed the same 
effectiveness. This observation can be explained by ox i -
dation of Fe 2 + to Fe 3 + and *0 2-, dismutation of the latter 
would yield H 2 0 2 , which in turn is oxidized by F e 2 + to 
finally generate O H (Schemes 3 - 5 ) [63]. 
A d d i t i o n o f the chelator D T P A almost completely can-
celled this inhibi t ion , since ferrous D T P A is relatively 
stable to oxidat ion [63]. The effects o f alkylperoxyl and 
2 Fe 2 + + 202 *~ 2 Fe 3 - + 2 -02" 
Scheme 3 
2 -02- + 2H+ *~ H 2 0 2 + 0 2 
Scheme 4 
Fe 2 + + H 2 0 2 - Fe 3 + + «OH + OH" 
Scheme 5 
alkoxyl radicals on G 6 - P D H were similar to those of 
O H . Incubation with H 2 0 2 and alkylhydroperoxides d id 
not produce any alteration of the enzyme activity. 
3.3.3. Superoxide anion radical 
02 (Table 3, entries 7—9), was the most potent inacti-
vating oxygen derivative towards G 6 - P D H at concentra-
tions which caused the same reduction rate of N B T as 
d i d 55 % o f a 10 umol/1 dithranol solution ( N B T reduc-
t ion by dithranol could be inhibi ted by S O D to this extent 
[24], indicating 55 % of the reduction to be caused by 
0 2 ) . G 6 - P D H activity was decreased to 60 %. Similar 
effects were achieved by addit ion of F e 2 + - D T P A or F e 3 + -
E D T A (Table 3, entries 10, 11) to the xanthine/XO-sys-
tem in order to produce O H as a secondary product. In 
this case it cannot be differentiated between the effects 
o f O H and 0 2 , but because O H generated by the Fen-
ton reaction (Table 3, entry 12) was only a modest inhib-
itor, these findings rather suggest that in this system ' 0 2 " 
is the inactivating species exerting the deleterious effects 
independently of its iron-catalyzed interaction with H^O^ 
[64]. 
O u r experiments with oxygen derivatives, produced in-
dependently of the drug, demonstrate that G 6 - P D H is 
inert to H 2 0 2 and *0 2 , but markedly susceptible to * 0 2 . 
Hydroxy l radical leads to a modest decrease of G 6 - P D H 
activity. In conclusion, i f dithranol acts through forma-
t ion of active oxygen species, ' 0 2 " is the potent species 
towards G 6 - P D H . 
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